GF-2023-header

13th WFH Global Forum covers latest advances in bleeding disorders treatments and technologies

The 13th World Federation of Hemophilia (WFH) Global Forum was held in Montreal, Canada, on November 17 and 18, 2023, and brought healthcare professionals, patient advocates, government officials, and industry members from around the world together. The gathering covered the very latest scientific developments and challenges related to the treatment of bleeding disorders. This year, the WFH Global Forum and the Gene Therapy Round Table were merged into one event. By integrating the two topics, attendees had the chance to hear from a wider spectrum of leading experts in the field of inherited bleeding disorders in one place, in-person.

Also available in: Français Español

Day 1 of the WFH Global Forum focused on confronting the limitations of therapy, from plasma to gene therapy, and discussing treatment for people with mild or moderate hemophilia, women and girls with bleeding disorders, and people with rare bleeding disorders. Talks on inequities in healthcare delivery globally and innovative access programs were also given.

Day 2 started with an inspiring keynote presentation by Andre Picard, award-winning health and public policy journalist. Picard emphasized the importance of remembering and learning from the past as we enter a new era of bleeding disorders treatments. The next sessions focused on different WFH programs, access to gene therapy globally, and new treatments and technologies in the pipeline.

The 13th Global Forum provided a unique opportunity for participants to come together and collectively reassess various therapeutic options—both established and new—and discuss challenges and opportunities for better care and treatment. To find out more about the 13th WFH Global Forum, please click here.

The 13th edition of the WFH Global Forum is supported by funding from BioMarin, CSL Behring, Pfizer, Sobi and Spark Therapeutics.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.